Retinoblastoma is a rare type of cancer, and its treatment, as well as diagnosis, is
challenging, owing to mutations in the tumor-suppressor genes and lack of targeted …

Ocular drug delivery is one of the most challenging endeavors among the various available
drug delivery systems. Despite having suitable drugs for the treatment of ophthalmic …

Abstract Treatment and management of diseases of the posterior segment of the eye such
as diabetic retinopathy, retinoblastoma, retinitis pigmentosa, and choroidal …

Nanocarriers, such as nanoparticles, have the capacity to deliver ocular drugs to specific
target sites and hold promise to revolutionize the therapy of many eye diseases. Results to …

Intrinsic shortcomings associated with conventional therapeutic strategies often compromise
treatment efficacy in clinical ophthalmology, prompting the rapid development of versatile …

Smart nano-micro platforms have been extensively applied for diverse biomedical
applications, mostly focusing on cancer therapy. In comparison with conventional …

Ocular diseases can deteriorate vision to the point of blindness and thus can have a major
impact on the daily life of an individual. Conventional therapies are unable to provide …

The advent of nanotechnology promises to drastically accelerate progress toward
nanomedicine. Nanoscale particles in the size range of cellular and molecular structures …

Retinoblastoma is the most common primary intraocular malignancy in children. Although
traditional chemotherapy has shown some success in retinoblastoma management, there …

Glaucoma is considered a leading cause of blindness with the human eye being one of the
body's most delicate organs. Ocular diseases encompass diverse diseases affecting the …